Details for Patent: 6,875,445
✉ Email this page to a colleague
Summary for Patent: 6,875,445
| Title: | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption |
| Abstract: | A composition for inhibiting gastrointestinal absorption of phosphorous in an individual. The composition includes a quantity of calcium acetate sufficient to bind the phosphorous in the gastrointestinal tract of the individual. The calcium acetate has a bulk density of between 0.50 kg/L and 0.80 kg/L and is dimensioned to form a caplet for fitting within a capsule in a manner that optimizes the volume of the capsule. Also provided is a method for administering the calcium acetate composition of the present invention to an individual to reduce phosphorous absorption by binding with the phosphorous in their gastrointestinal tract. |
| Inventor(s): | Edmund V. Dennett, Jr., Robert M. Raleigh, Jr., Bruce H. Aronson |
| Assignee: | Braintree Laboratories Inc , Fresenius Medical Care Holdings Inc |
| Application Number: | US10/279,598 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,875,445 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Device; Dosage form; |
| Patent landscape, scope, and claims: |
More… ↓ |
Drugs Protected by US Patent 6,875,445
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
